IL6 and type 2 diabetes mellitus: Overall, these results show that a 3-month clinical intervention with L-GSH supplementation in T2DM subjects resulted in significantly less production of IL-6, and IL-10 in response to an in vitro M. tb infection when compared to T2DM subjects prior to L-GSH supplementation.